1. Home
  2. USBC vs DERM Comparison

USBC vs DERM Comparison

Compare USBC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USBC

USBC Inc.

HOLD

Current Price

$0.57

Market Cap

228.4M

Sector

N/A

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$8.02

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USBC
DERM
Founded
N/A
2014
Country
United States
Employees
24
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.4M
210.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
USBC
DERM
Price
$0.57
$8.02
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.67
AVG Volume (30 Days)
N/A
129.3K
Earning Date
N/A
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$59,399,000.00
Revenue This Year
N/A
$17.48
Revenue Next Year
N/A
$55.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.82
52 Week Low
N/A
$3.54
52 Week High
N/A
$9.40

Technical Indicators

Market Signals
Indicator
USBC
DERM
Relative Strength Index (RSI) 34.31 53.99
Support Level $0.57 $7.15
Resistance Level $0.61 $8.40
Average True Range (ATR) 0.04 0.41
MACD -0.00 0.08
Stochastic Oscillator 11.25 72.03

Price Performance

Historical Comparison
USBC
DERM

About USBC USBC Inc.

USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Share on Social Networks: